BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33592845)

  • 1. A dynamic model of the Coronavirus Disease 2019 outbreak to analyze the effectiveness of control measures.
    Yang S; Liu Y; Chen K; Li T; Huang Y; Chen X; Qi P; Xu Y; Yu F; Yang Y; Chen Y
    Medicine (Baltimore); 2021 Feb; 100(5):e23925. PubMed ID: 33592845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.
    Ke Y; Cui J; Wong Y
    J Epidemiol Glob Health; 2021 Mar; 11(1):42-45. PubMed ID: 33009735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital contact tracing technologies in epidemics: a rapid review.
    Anglemyer A; Moore TH; Parker L; Chambers T; Grady A; Chiu K; Parry M; Wilczynska M; Flemyng E; Bero L
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013699. PubMed ID: 33502000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
    PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
    Kucharski AJ; Klepac P; Conlan AJK; Kissler SM; Tang ML; Fry H; Gog JR; Edmunds WJ;
    Lancet Infect Dis; 2020 Oct; 20(10):1151-1160. PubMed ID: 32559451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study.
    Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C
    Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding South Korea's Response to the COVID-19 Outbreak: A Real-Time Analysis.
    Jeong E; Hagose M; Jung H; Ki M; Flahault A
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social Distance in COVID-19: Drawing the line between protective behavior and stigma manifestation.
    Economou M
    Psychiatriki; 2021 Sep; 32(3):183-186. PubMed ID: 34390552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
    Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the Effectiveness of Non-Pharmaceutical Interventions on COVID-19 Control in Korea.
    Min KD; Kang H; Lee JY; Jeon S; Cho SI
    J Korean Med Sci; 2020 Sep; 35(35):e321. PubMed ID: 32893522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities.
    Huang B; Wang J; Cai J; Yao S; Chan PKS; Tam TH; Hong YY; Ruktanonchai CW; Carioli A; Floyd JR; Ruktanonchai NW; Yang W; Li Z; Tatem AJ; Lai S
    Nat Hum Behav; 2021 Jun; 5(6):695-705. PubMed ID: 33603201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Chen YH; Fang CT; Huang YL
    Int J Infect Dis; 2021 Sep; 110():213-221. PubMed ID: 34333119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of control measures on COVID-19 transmission in South Korea.
    Lee T; Kwon HD; Lee J
    PLoS One; 2021; 16(3):e0249262. PubMed ID: 33780504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glance at the prevalence of coronavirus disease 19 (COVID-19) in Iran: Strengths and weaknesses.
    Mohammadzadeh N; Shahriary M; Shirmohammadlou N; Lohrasbi V
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1479-1482. PubMed ID: 32362292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.